Work

Le rôle d’IGFBP2 dans la dysfonction podocytaire et le développement de la néphropathie diabétique

Year: 2021
Type: dissertation
Abstract: Diabetic nephropathy (DN) is the leading cause of end-stage renal disease in North America. Podocytes are essential for glomerular filtration mechanisms. Several studies have shown that their apoptosis correlates strongly with the progression of DN. Podocytes are a target for insulin-like growth factor (IGF), an important growth factor for the integrity of cells. Abnormalities in IGF signaling are associated with podocyte dysfunction. The IGFBP2 protein is known to interact with IGF by limiting its actions as well as for IGF-independent actions. Results from our collaborator showed that circulating levels of IGFBP2 were reduced by approximately 33% in type 2 diabetic obese adolescents compared to obese but normoglycemic controls. This reduction was correlated with microalbuminuria and other inflammatory markers. Since the role of IGFBP2 in the development of DN is still unknown, our objectives are to characterize the expression of IGFBP2 in the IGF signaling pathway in podocytes exposed to high glucose concentrations (HG) and/or with saturated fatty acids (palmitate) and to study the role of IGFBP2 in the development of DN in both IGFBP2- deficient or overexpressing mice with type 1 diabetes (Akita). Podocytes stimulated with IGF-2 show an increase in the phosphorylation of Akt and ERK1/2 while palmitate reduces this activation. Hyperglycemia weakly activates these pathways in the presence of IGF-2 and palmitate. Using a recombinant IGFBP2 shows that podocytes activate ERK1/2 protein without IGF, whereas stimulation with IGF-2 and recombinant IGFBP2 shows no activation for Akt and IGF1Rβ. Palmitate prevents activation of ERK1/2 under all conditions but does not reduce Akt phosphorylation and even promotes activation of IGF1Rβ in the presence of IGF-2. Diabetic Akita mice overexpressing IGFBP2 exhibit decreased blood pressure, lower mesangial area, increased plasmatic and glomerular levels of IGFBP2 and a greater activation of Akt than diabetic mice. On the opposite, IGFBP2-deficient Akita mice have higher weight and Akt activation as well as lower glomerular areas, mesangial areas, albuminuria and glomerular filtration rate (GFR) than diabetic mice. In conclusion, excess or complete loss of IGFBP2 causes adverse effects participating in the progression of DN. Controlling the expression of IGFBP2 could help reduce the development of DN.
Author: Dancosst, David-Alexandre
Language: French
Subfield: Nephrology
Field: Medicine
Open Access status: green
OpenAlex ID: W7048461594
Cites: 118
Cited by:
Related to: 10